Breast Implant Update.

 

 

 

 

 

 

 

You may be aware of some recent media on the safety of breast implants. These concern the incidence of a form of lymphoma called ALCL. It has occurred in 46 women of the hundreds of thousands of women who have implants in Australia.

Here are some of the important facts patients should be aware of:

  • ALCL is related to the contamination of the implant during insertion.
  • ALCL is very rare.
  • It generally develops 3-14 years after insertion and presents as a lump.
  • It is NOT breast cancer.
  • ALCL develops in a capsule of fluid around the breast implant, not in the breast tissue itself.
  • Majority of cases are cured by the removal of the implant.
  • The technique that Dr Briggs uses aims to prevent contamination of the Implant upon insertion. He has committed to the Macquarie University 14 point plan to reduce infection risk.
    Regardless of how long ago Dr Briggs’ patients underwent Breast Augmentation surgery, they can be reassured their surgery was performed in accordance with the protocols to minimise the risk of infection and ALCL.
  • Your consultation is an opportunity to discuss all risks associated with surgery.
  • Dr Briggs uses implants from one of the world’s leading implant manufacturers, Allergan. Allergan implants are backed by a life-time guarantee and have a demonstrated safety record and low rates of implant-related complications.

Are you concerned about a change in your breast?

If you are concerned about your breast implants, particularly swelling or hardening, then please immediately seek medical advice from your GP or if you had your surgery here, you should book an appointment with our surgeons. The first step is generally an ultrasound to investigate the source of swelling, which in most cases is not related to ALCL.

Looking for more information?

Dr Briggs is a member of both the Australasian Society of Aesthetic Plastic Surgeons and Australian Society of Plastic Surgeons which have released a statement reinforcing the rare nature of ALCL and the commitment amongst their members to reduce infection risk by committing as Dr Briggs has, to the 14 point plan. See the ASAPS/ASPS statement here.